Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies

Interstitial lung disease (ILD) is a leading cause of mortality in systemic sclerosis (SSc). However, mortality is improving as pathogenesis is being better understood and new therapies emerge. The roles of the inflammasome and NETosis in fibrosis are being elucidated. Epigenetic targets like DNA me...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mediterr J Rheumatol
Autors principals: Ahmed, Sakir, Pattanaik, Sarit Sekhar, Rai, Mohit Kumar, Nath, Alok, Agarwal, Vikas
Format: Artigo
Idioma:Inglês
Publicat: The Mediterranean Journal of Rheumatology (MJR) 2018
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046043/
https://ncbi.nlm.nih.gov/pubmed/32185315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.29.3.140
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars